Genetics of Prostate Cancer (PDQ®): Genetics - Health Professional Information [NCI] - Introduction
Many of the medical and scientific terms used in this summary are found in the NCI Dictionary of Genetics Terms. When a linked term is clicked,the definition will appear in a separate window. The public health burden of prostate cancer is substantial. A total of 186,320 new cases of prostate cancer and 28,660 deaths from the disease are anticipated in the United States in 2008,making it the ...
Prostate Cancer Screening (PDQ®): Screening - Patient Information [NCI] - nci_ncicdr0000258032-nci-header
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Prostate Cancer Screening
Genetics of Prostate Cancer (PDQ®): Genetics - Health Professional Information [NCI] - Interventions in Familial Prostate Cancer
Refer to the PDQ summaries on Screening for Prostate Cancer; Prevention of Prostate Cancer; and Prostate Cancer Treatment for more information on interventions for sporadic nonfamilial forms of prostate cancer. As with any disease process,decisions about risk-reducing interventions for patients with an inherited predisposition to prostate cancer are best guided by randomized controlled clinical ...
Prostate Cancer Prevention (PDQ®): Prevention - Patient Information [NCI] - nci_ncicdr0000062853-nci-header
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Prostate Cancer Prevention
Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Patient Information [NCI] - Overview of CAM Use in Prostate Cancer
Studies of CAM use to treat prostate cancer have shown the following:Men who have prostate cancer are more likely to take dietary supplements than men who do not have prostate cancer.Prostate cancer patients with the healthiest eating habits (for example, eating lots of fish rich in omega-3 fatty acids and vegetables) are the most likely to take dietary supplements.Popular dietary supplements used by prostate cancer patients include lycopene, vitamin E, selenium, and saw palmetto.Reasons given by prostate cancer patients for using CAM treatments include boosting the immune system, improving quality of life, and lowering the risk of the cancer coming back.Studies of CAM use to lower the risk of developing prostate cancer or to prevent it from coming back have shown the following:A study of men with a family history of prostate cancer found that over half used vitamins or other dietary supplements, including those sold for prostate health or cancer prevention such as selenium, green
Prostate Cancer Prevention (PDQ®): Prevention - Patient Information [NCI] - What is prevention?
WebMD discusses methods of preventing prostate cancer.
Prostate Cancer Prevention (PDQ®): Prevention - Patient Information [NCI] - Questions or Comments About This Summary
If you have questions or comments about this summary,please send them to Cancer.gov through the Web site’s Contact Form. We can respond only to email messages written in English. ...
Genetics of Prostate Cancer (PDQ®): Genetics - Health Professional Information [NCI] - Changes to This Summary (02 / 15 / 2013)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.IntroductionUpdated statistics with estimated new cases and deaths for 2013 (cited American Cancer Society as reference 1).Updated statistics with age-specific probabilities of being diagnosed with prostate cancer in 2013.Genes With Potential Clinical Relevance in Prostate Cancer Risk This section was comprehensively reviewed and extensively revised.Methods of Prostate Cancer Genetic ResearchAdded American Cancer Society as reference 4.Added 2q37 to the list of chromosomal regions with modest-to-strong statistical significance (logarithm of the odds score ≥2) identified by genome-wide linkage studies of families with prostate cancer (cited Cropp et al. as reference 87). Added text about a study of 10,501 prostate cancer cases and 10,831 controls from multiple cohorts who were genotyped for
Prostate Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - To Learn More About Prostate Cancer
For more information from the National Cancer Institute about prostate cancer,see the following: Prostate Cancer What You Need to Know About™ Prostate Cancer Prostate Cancer Prevention Prostate Cancer Screening Treatment Choices for Men with Early-Stage Prostate Cancer Early Prostate Cancer: Questions and Answers The Prostate-Specific Antigen (PSA) Test: Questions and Answers Cryosurgery in ...
Prostate Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Treatment Option Overview for Prostate Cancer
Local treatment modalities are associated with prolonged disease-free survival for many patients with localized prostate cancer but are rarely curative in patients with locally extensive tumors. Because of clinical understaging using current diagnostic techniques, even when the cancer appears clinically localized to the prostate gland, some patients develop disseminated tumors after local therapy with surgery or radiation. Metastatic prostate cancer is currently not curable.Treatment options for each stage of prostate cancer are presented in Table 9.Table 9. Treatment Options by Stage for Prostate CancerStage (TNM Staging Criteria)Standard Treatment OptionsTURP = transurethral resection of the prostate.Stage I Prostate CancerWatchful waiting or active surveillanceRadical prostatectomyExternal-beam radiation therapy (EBRT)Interstitial implantation of radioisotopesStage II Prostate CancerWatchful waiting or active